Cargando…
No evidence for circulating HuD-specific CD8(+) T cells in patients with paraneoplastic neurological syndromes and Hu antibodies
AIM: In paraneoplastic neurological syndromes (PNS) associated with small cell lung cancer (SCLC) and Hu antibodies (Hu-PNS), Hu antigens expressed by the tumour hypothetically trigger an immune response that also reacts with Hu antigens in the nervous system, resulting in tumour suppression and neu...
Autores principales: | de Beukelaar, Janet W., Verjans, Georges M., van Norden, Yvette, Milikan, Johannes C., Kraan, Jaco, Hooijkaas, Herbert, Sintnicolaas, Kees, Gratama, Jan W., Sillevis Smitt, Peter A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914259/ https://www.ncbi.nlm.nih.gov/pubmed/17597332 http://dx.doi.org/10.1007/s00262-007-0295-2 |
Ejemplares similares
-
Tolerance to the Neuron-Specific Paraneoplastic HuD Antigen
por: DeLuca, Ilana, et al.
Publicado: (2009) -
Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes
por: Bastiaansen, Anna E M, et al.
Publicado: (2021) -
HuB and HuD repress telomerase activity by dissociating HuR from TERC
por: Cheng, Xiaolei, et al.
Publicado: (2021) -
Expression of HuD (a paraneoplastic encephalomyelitis antigen) mRNA in lung cancer.
por: Cho, J. H., et al.
Publicado: (1997) -
Study on the pro-inflammatory mechanism of the HuD antibody in promoting M1 polarization and paraneoplastic neurological syndrome occurrence
por: Yin, Liang, et al.
Publicado: (2022)